AFAhmed Ferchiou

Ahmed Ferchiou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ahmed Ferchiou has a total of 24 co-authors. Here are the top co-authors by number of shared publications:

  • Didier Raboisson

    Affiliation UMR ASTRE, Université de Toulouse, CIRAD, INRAE, ENVT, Toulouse, France

    5 shared publications
  • Didier Raboisson

    Université de Toulouse, École nationale vétérinaire de Toulouse (ENVT), F-31076, Toulouse, France

    4 shared publications
  • Guillaume Lhermie

    CIRAD, UMR ASTRE, Montpellier, France, ASTRE, CIRAD, INRAE, Université de Montpellier, Montpellier, Université de Toulouse, ENVT, 31300 Toulouse, France; Faculty of veterinary medicine, University of Calgary, Calgary, T2N 1N4, Alberta, Canada

    4 shared publications
  • Guillaume Lhermie

    Faculty of Veterinary Medicine, University of Calgary, Calgary, Canada

    4 shared publications
  • Mehdi Berrada

    CIRAD, UMR ASTRE, Montpellier, France, ASTRE, CIRAD, INRAE, Univ Montpellier, Montpellier, Université de Toulouse, ENVT, Toulouse, France

    2 shared publications
  • Nicolas Herman

    Affiliation Clinique Vétérinaire Des Mazets, Les Mazets, Riom-ès-Montagnes, France

    2 shared publications

Latest Publications

  • Open Access

    Economics of vaccination against diarrhoea and respiratory diseases in French cow calves’ systems: A modelling approach

    by Ahmed Ferchiou, Anthony Giacomini, Nicolas Herman, Guillaume Lhermie, Didier Raboisson

    To assess the economic benefits of vaccination against diarrhoea and respiratory diseases in cow-calf systems, a stochastic mechanistic mathematical programming bio-economic model was developed for a beef Charolais breed farm. The model reproduced herd dynamics on a weekly basis over a 10-year period, including animal growth, reproduction and diseases risks and control (treatments and vaccination). Three baseline risk levels of diarrhoea and respiratory disease were considered to simulate low, average, and high infection risks on the farm. The results demonstrated the model’s ability to reproduce average farm dynamics, with diarrhoea prevalence ranging from 8% to 33% and respiratory diseases from 13% to 79%. On average, prevalences were decreased by 24% and 50%, respectively, due to vaccination, which also reduced the 2-day to 1-month mortality rates by 2–3% and 15–17%, respectively. The net value of vaccination was positive except in cases of low infection risk of diarrhoea and respiratory diseases: the return on investment (ROI) of vaccination was 0.4–0.5 (€1 invested yields €0.4–0.5) in the baseline scenario (middle infection risks), negative under low infection risks, and reached 1 (€1 invested yields €1) for high infection risks. The results also showed that farmers may earn €58–75 in additional revenue per extra hour of labour dedicated to vaccination in the medium-risk scenario. Despite the limited availability of data for cow-calf systems, this study demonstrated the economic benefit of vaccination in most combinations of scenarios and risks. The profitability of vaccination was challenged when low disease risks were considered, but in such cases, vaccination may serve as insurance against financial losses in case of health status deterioration.

  • Open Access

    Dairy farmer income, working time, and antimicrobial use under different dry cow therapy protocols

    by Thomas Le Page, Ahmed Ferchiou, Simon Dufour, Fidèle Kabera, Jocelyn Dubuc, Guillaume Lhermie, Didier Raboisson, Jean-Philippe Roy

    Mastitis is one of the most common diseases of dairy cattle. It has a high impact on-farm economy, farmers' working time, and antimicrobial usage (AMU). Selective dry cow therapy (SDCT) is an effective means of reducing AMU without negatively affecting udder health. The objective of our study was to evaluate the impact of SDCT implementation on farmer income, working time, and AMU, using a bioeconomic model. A stochastic dairy simulation model (DairyHealthSim) based on a weekly model was used to simulate herd dynamics, reproduction, milk production, culling decisions, health outcomes, and the management of health events. A specific module was developed for the simulation of quarter-level IMI acquisition and elimination during the lactation and dry-off periods, and 25 different farm settings were defined to represent herds with various udder health situations. We then defined 20 scenarios of SDCT by combining both the use of different thresholds of SCC and milk bacteriology for treatment allocation and the use of internal teat sealant (ITS). All SDCT protocols had little effect on farmer income, and we identified some protocols with a positive farm gross margin (up to Can$15.83/dried cow; at time of writing, Can$1 = US$0.72). We also found that adding an ITS to all cows led to greater economic gain. The application of SDCT had little effect on farmers' working time, except when milk bacteriology was used for decision making. Antimicrobial treatment to all cows above 200,000 cells/mL at last control, with the use of ITS on all cows, seems a good choice in most dairy farms. These findings could be used to convince farmers to adopt this strategy at dry-off.


  • Open Access

    Management of Digital Dermatitis in Dairy Herds: Optimization and Time Allocation

    by Rodolphe Robcis, Ahmed Ferchiou, Mehdi Berrada, Didier Raboisson

    The objective of this study is to determine the most effective time allocation for digital dermatitis management and to quantify the marginal economic gain from extra time devoted to digital dermatitis management. The model simulating foot disease occurrence and the associated management was Dairy Health Simulator©. Then, an econometric model was applied to identify the relationship between the dairy workshop’s gross margin and time for lameness management as well as the hourly marginal gain curve associated with lameness management. The gross margin was optimized under two constraints, i.e., the overall time spent for lameness management and the mean lameness duration (mimicking cow welfare). The results show that allocating less time to lameness detection and more to footbath application can contribute as follows: (i) reduces time spent for lameness management, (ii) maintains the best welfare level, and (iii) obtains the highest gross margin. The optimal time to devote to footbath application ranged from 17.8 to 22.3 h/month. A hiring strategy was investigated, and the break-even point ranged from 16.1 to 19.8 h/month. The recommended time to spend on footbath application is relatively important; therefore, stakeholders should consider the importance of lameness to the dairy industry and should devote enough time for footbath applications.


  • Open Access

    Cost of lameness in dairy herds: An integrated bioeconomic modeling approach

    by Rodolphe Robcis, Ahmed Ferchiou, Mehdi Berrada, Youba Ndiaye, Nicolas Herman, Guillaume Lhermie, Didier Raboisson

    Foot disorders are costly health disorders in dairy farms, and their prevalence is related to several factors such as breed, nutrition, and farmer's management strategy. Very few modeling approaches have considered the dynamics of foot disorders and their interaction with farm management strategies within a holistic farm simulation model. The aim of this study was to estimate the cost of foot disorders in dairy herds by simulating strategies for managing lameness. A dynamic and stochastic simulation model (DairyHealthSim) was used to simulate the herd dynamics, reproduction management, and health events. A specific module was built for lameness and related herd-level management strategies. Foot disorder occurrences were simulated with a base risk for each etiology [digital dermatitis (DD), interdigital dermatitis, interdigital phlegmon, sole ulcer (SU), white line disease (WLD)]. Two state machines were implemented in the model: the first was related to the disease-induced lameness score (from 1 to 5), and the second concerned DD-state transitions. A total of 880 simulations were run to represent the combination of the following 5 scenarios: (1) housing (concrete vs. textured), (2) hygiene (2 different scraping frequencies), (3) the existence of preventive trimming, (4) different thresholds of DD prevalence detected and from which a collective footbath is applied to treat DD, and (5) farmer's ability to detect lameness (detection rate). Housing, hygiene, and trimming scenarios were associated with risk factors applied for each foot disorder etiologies. The footbath and lameness detection scenarios both determined the treatment setup and the policy of herd observance. The economic evaluation outcome was the gross margin per year. A linear regression model was run to estimate the cost per lame cow (lameness score ≥3), per case of DD and per week of a cow's medium lameness duration. The bioeconomic model reproduced a lameness prevalence varying from 26 to 98% depending on the management scenario, demonstrating a high capacity of the model to represent the diversity of the field situations. Digital dermatitis represented half of the total lameness cases, followed by interdigital dermatitis (28%), SU (19%), WLD (13%), and interdigital phlegmon (4%). The housing scenarios dramatically influenced the prevalence of SU and WLD, whereas scraping frequency and threshold for footbath application mainly determined the presence of DD. Interestingly, the results showed that preventive trimming allowed a better reduction in lameness prevalence than spending time on early detection. Scraping frequency was highly associated with DD occurrence, especially with a textured floor. The regression showed that costs were homogeneous (i.e., did not change with lameness prevalence; marginal cost equals average cost). A lame cow and a DD-affected cow cost €307.50 ± 8.40 (SD) and €391.80 ± 10.0 per year on average, respectively. The results also showed a cost of €12.10 ± 0.36 per week-cow lameness. The present estimation is the first to account for interactions between etiologies and for the complex DD dynamics with all the M-stage transitions, bringing a high level of accuracy to the results.


  • Open Access

    The Marginal Abatement Cost of Antimicrobials for Dairy Cow Mastitis: A Bioeconomic Optimization Perspective

    by Ahmed Ferchiou, Youba Ndiaye, Mostafa A. Mandour, Nicolas Herman, Guillaume Lhermie, Didier Raboisson

    Maintaining udder health is the primary indication for antimicrobial use (AMU) in dairy production, and modulating this application is a key factor in decreasing AMU. Defining the optimal AMU and the associated practical rules is challenging since AMU interacts with many parameters. To define the trade-offs between decreased AMU, labor and economic performance, the bioeconomic stochastic simulation model DairyHealthSim (DHS)© was applied to dairy cow mastitis management and coupled to a mean variance optimization model and marginal abatement cost curve (MACC) analysis. The scenarios included three antimicrobial (AM) treatment strategies at dry-off, five types of general barn hygiene practices, five milking practices focused on parlor hygiene levels and three milk withdrawal strategies. The first part of economic results showed similar economic performances for the blanked dry-off strategy and selective strategy but demonstrated the trade-off between AMU reduction and farmers’ workload. The second part of the results demonstrated the optimal value of the animal level of exposure to AM (ALEA). The MACC analysis showed that reducing ALEA below 1.5 was associated with a EUR 10,000 loss per unit of ALEA on average for the farmer. The results call for more integrative farm decision processes and bioeconomic reasoning to prompt efficient public interventions.


  • Open Access

    Multi-Criteria Decision Analysis for Assessing Social Acceptance of Strategies to Reduce Antimicrobial Use in the French Dairy Industry

    by Diego Manriquez, Maiara Costa, Ahmed Ferchiou, Didier Raboisson, Guillaume Lhermie

    To respond to the antimicrobial resistance (AMR) threat, public health entities implement policies aiming to reduce antimicrobial use (AMU) in livestock systems, in which policy success and sustainability might be subject to the social acceptability of the novel regulatory environment. Therefore, consistent methods that gather and synthesize preferences of stakeholder groups are needed during the policy design. The objective of this study was to present a methodology for evaluating the acceptability of potential strategies to reduce AMU using multi-criteria decision analysis (MCDA) using French dairy industry as a model. Preference-ranking organization methods for enrichment evaluations were applied to rank stakeholders’ acceptance of four different potential AMU reduction strategies: 1. Baseline AMU regulations in France; 2. Total interdiction of AMU; 3. Interdiction of prophylaxis and metaphylaxis AMU; and 4. Subsidies to reduce AMU by 25%. A total of 15 stakeholders (consumers, n = 10; farmers, n = 2; public health representatives, n = 3) representing the French dairy sector and public health administration participated in the acceptance weighting of the strategies in relation with their impact on environmental, economic, social, and political criteria. We established a MCDA methodology and result-interpretation approach that can assist in prioritizing alternatives to cope with AMR in the French dairy industry or in other livestock systems. Our MCDA framework showed that consumers and public health representatives preferred alternatives that consider the restriction of AMU, whereas farmers preferred to maintain baseline policy.


  • Open Access

    Could Contracts between Pharmaceutical Firms and French Veterinarians Bias Prescription Behaviour: A Principal-Agency Theory Approach in the Context of Oligopolies

    by Didier Raboisson, Ahmed Ferchiou, Tifenn Corre, Sylvain Perez, Pierre Sans, Guillaume Lhermie, Marie Dervillé

    In France, veterinarians can both prescribe and deliver veterinary medicines, which is a questionable situation from the perspective of antimicrobial use (AMU) reduction to avoid antimicrobial resistance (AMR). This situation places veterinarians in direct commercial relationships with the pharmaceutical industry as purchase contracts are signed between veterinarians and pharmaceutical companies. The aim of the present work is to analyse the relationships between veterinarians and pharmaceutical firms in the oligopoly market context of French veterinary medicine to determine whether the prescription behaviour of practitioners can be biased by joint prescription and delivery. Therefore, we develop an analysis based on principal-agent theory. Contracts between pharmaceutical companies and veterinarians during the 2008–2014 period were analysed based on 382 contracts related to 47 drugs belonging to eight main pharmaceutical firms (2320 observations). The price per unit after rebate of each drug and contract was calculated. The descriptive analysis demonstrated high disparity among the contracts across pharmaceutical firms with regard to the provisions of the contracts and how they are presented. Then, linear regression was used to explain the price per unit after rebate based on the explanatory variables, which included the yearly purchase objective, year, type of drug and type of rebate. The decrease in price per unit after rebate for each extra €1000 purchase objective per drug category was established to be €0.061 per 100 kg body weight for anticoccidiosis treatments, €0.029 per 100 kg body weight for anti-inflammatories, €0.0125 per 100 kg body weight and €0.0845 per animal for antiparasitics, and €0.031 per animal for intramammary antimicrobials. Applying agency theory reveals that veterinarians can be considered agents in the case of monopolistic situations involving pharmaceutical firms; otherwise, veterinarians are considered principals (oligopolistic situations in which at least several medicines have similar indications). The present study does not provide evidence suggesting that joint prescription and delivery may introduce any potential prescription bias linked to conflicts of interest under the market conditions during the 2008–2014 period.


  • Open Access

    Individual Behaviors and COVID-19 Lockdown Exit Strategy: A Mid-Term Multidimensional Bio-economic Modeling Approach

    by Ahmed Ferchiou, Remy Bornet, Guillaume Lhermie, Didier Raboisson

    As of mid-2020, eradicating COVID-19 seems not to be an option, at least in the short term. The challenge for policy makers consists of implementing a suitable approach to contain the outbreak and limit extra deaths without exhausting healthcare forces while mitigating the impact on the country's economy and on individuals' well-being. To better describe the trade-off between the economic, societal and public health dimensions, we developed an integrated bioeconomic optimization approach. We built a discrete age-structured model considering three main populations (youth, adults and seniors) and 8 socio-professional characteristics for the adults. Fifteen lockdown exit strategies were simulated for several options: abrupt or progressive (4 or 8 weeks) lockdown lift followed by total definitive transitory final unlocking. Three values of transmission rate (Tr) were considered to represent individuals' barrier gesture compliance. Optimization under constraint to find the best combination of scenarios and options was performed on the minimal total cost for production losses due to contracted activities and hospitalization in the short and mid-term, with 3 criteria: mortality, person-days locked and hospital saturation. The results clearly show little difference between the scenarios based on the economic impact or the 3 criteria. This means that policy makers should focus on individuals' behaviors (represented by the Tr value) more than on trying to optimize the lockdown strategy (defining who is unlocked and who is locked). For a given Tr, the choices of scenarios permit the management of the hospital saturation level with regard to both its intensity and its duration, which remains a key point for public health. The results highlight the need for behavioral or experimental economics to address COVID-19 issues through a better understanding of individual behavior motivations and the identification of ways to improve biosecurity compliance.


  • Open Access

    Individual behaviours and COVID-19 lockdown exit strategy: a mid-term multidimensional bio-economic modelling approach

    by Ahmed Ferchiou, Remy Bornet, Guillaume Lhermie, Didier Raboisson

    As of mid-2020, eradicating COVID-19 seems not to be an option, at least in the short term. The challenge for policy makers consists of implementing a suitable approach to contain the outbreak and limit extra deaths without exhausting healthcare forces while mitigating the impact on the country's economy and on individuals’ well-being. To better describe the trade-off between the economic, societal and public health dimensions, we developed an integrated bioeconomic optimization approach. We built a discrete age-structured model considering three main populations (youth, adults and seniors) and 8 socio-professional characteristics for the adults. Fifteen lockdown exit strategies were simulated for several options: abrupt or progressive (4 or 8 weeks) lockdown lift followed by total definitive transitory final unlocking. Three values of transmission rate (Tr) were considered to represent individuals’ barrier gesture compliance. Optimization under constraint to find the best combination of scenarios and options was performed on the minimal total cost for production losses due to contracted activities and hospitalization in the short and mid-term, with 3 criteria: mortality, person-days locked and hospital saturation. The results clearly show little difference between the scenarios based on the economic impact or the 3 criteria. This means that policy makers should focus on individuals’ behaviours (represented by the Tr value) more than on trying to optimize the lockdown strategy (defining who is unlocked and who is locked). For a given Tr, the choices of scenarios permit the management of the hospital saturation level with regard to both its intensity and its duration, which remains a key point for public health. The results highlight the need for behavioural or experimental economics to address COVID-19 issues through a better understanding of individual behaviour motivations and the identification of ways to improve biosecurity compliance.